drugset / Trial / NCT01177709

Metformin for Weight Loss in Schizophrenia

NCT01177709 ↗

NaSingle-groupOpen-labelTreatment

Summary

Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.

Timeline

Start
2008-05
Primary completion
2011-04
Completion
2011-04

Outcome

Outcome not reported

Stopped: “PI moved to different institution. Decided to concentrate on different studies.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 2500 mg —